Ask AI
H.R. 6977

Independent Drug Value Assessment Act of 2024

A plain-language summary from the Congressional Research Service isn’t available yet for this bill. CRS summaries are typically posted within a few weeks of introduction.

Referred to the Subcommittee on Health.

Rep. Nadler, Jerrold [D-NY-12](D-NY)Sponsor
2 cosponsors2 D
2cosponsors1committees4actions
  1. Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  2. IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  3. IntroReferralIntro-H

    Introduced in House

  4. IntroReferral1000

    Introduced in House

Independent Drug Value Assessment Act of 2024 — Informed